Fullhope Biomedical Co (7773.TWO) Stock Price

Fullhope Biomedical Co Price

CLOSED
29.50
​
Market closed

Over the last 2 years Fullhope Biomedical Co grew revenue by 19.7% annually, reaching 20.51 M TWD. For Fullhope Biomedical Co, the net margin of -272.6% is up versus -305.8% a few years ago.

Fullhope Biomedical Co stock price

Access this data via the Eulerpool API

Fullhope Biomedical Co business model & stock analysis

Fullhope Biomedical Co Ltd is a TW-based company operating in Biotechnology industry. The company is headquartered in Taipei, New Taipei. The company went IPO on 2024-09-26. Fullhope Biomedical Co Ltd is a Taiwan-based company that focuses on precision diagnosis and regenerative medicine-related products and develops corresponding products. In the precision diagnosis business, the Company has established an immune function analysis platform and a circulating tumor cell analysis platform to provide complete immune system status and circulating tumor cell information, which can be used as follow-up disease treatment strategies. In the regenerative medicine business, the Company has a Good Tissue Practice (GTP) laboratory that complies with regulations and regulations and has established a complete immune cell and stem cell-related manufacturing platform to produce a number of cell products.

Frequently asked questions about Fullhope Biomedical Co

Converted at the current exchange rate, the Fullhope Biomedical Co share trades at 0.82 EUR (29.50 TWD).

The revenue cannot currently be calculated for Fullhope Biomedical Co.

The profit cannot currently be calculated for Fullhope Biomedical Co.

The P/E ratio cannot be calculated for Fullhope Biomedical Co at the moment.

The P/S cannot be calculated for Fullhope Biomedical Co currently.

The Eulerpool Quality Score for Fullhope Biomedical Co is 2/10.

The ISIN of Fullhope Biomedical Co is TW0007773004. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Fullhope Biomedical Co is 7773.TWO. The ticker symbol is used to trade Fullhope Biomedical Co shares on the stock exchange.

Fair ValueTerminal
26.85 TWD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Biotechnology
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website fhb.com.tw
Country
Taiwan
Currency
TWD
Initial public offering
Sep 26, 2024
ISIN
TW0007773004
Cusip
Y266AZ101
Market capitalization
1.18 B TWDSmall Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/Se
—
EV/EBIT
—
P/B Ratio
2.01
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-9.37 %
Last updated Oct 10, 2026, 10:43 PM

Fullhope Biomedical Co Peer Group